Ulcerative colitis: efficacy and safety of tofacitinib studied

被引：0
|
作者：
Kessing, Richard
机构：
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2023年 / 61卷 / 10期
关键词：
D O I：
10.1055/a-2090-7258
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Wissenschaftler*innen des kanadischen IBD-Forschungskonsortiums bewerteten im Rahmen der multizentrischen Kohortenstudie REMIT-UC die Wirksamkeit und Sicherheit des selektiven Januskinasen-Inhibitors Tofacitinib bei der Behandlung von Colitis ulcerosa (CU) unter Praxisbedingungen.
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Tofacitinib in Ulcerative Colitis-evolving Efficacy and Safety
    Tiwari, Avinash
    Ashraf, Aadil
    Bharali, Pankaj
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2023, 57 (04) : 429 - 429
  • [2] Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative Colitis
    Sandborn, William J.
    Peyrin-Biroulet, Laurent
    Quirk, Daniel
    Wang, Wenjin
    Nduaka, Chudy, I
    Mukherjee, Arnab
    Su, Chinyu
    Sands, Bruce E.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (08) : 1821 - +
  • [3] Pharmacology and safety of tofacitinib in ulcerative colitis
    Lopez-Sanroman, Antonio
    Esplugues, Juan, V
    Domenech, Eugeni
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2021, 44 (01): : 39 - 48
  • [4] Efficacy of tofacitinib treatment in ulcerative colitis
    Panes, Julian
    Gisbert, Javier P.
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2019, 42 (06): : 403 - 412
  • [5] Tofacitinib Effectiveness and Safety as Therapy for Ulcerative Colitis
    McNally, M.
    Keating, E.
    Gray, E.
    McCormick, E.
    Carroll, A.
    Palmer, C.
    Kennedy, U.
    McKiernan, S.
    MacCarthy, F.
    Dunne, C.
    Hartery, K.
    Egan, L.
    Slattery, E.
    Ryan, B.
    McNamara, D.
    O'Connor, A.
    Breslin, N.
    O'Donnell, S.
    Cullen, G.
    Mulcahy, H.
    Sheridan, J.
    Doherty, G.
    Kevans, D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I431 - I431
  • [6] Efficacy and safety of tofacitinib in Ulcerative Colitis patients with extraintestinal manifestations in OCTAVE Open
    Rubin, D. T.
    Vavricka, S. R.
    Armuzzi, A.
    Dubinsky, M. C.
    Sharara, A. I.
    Modesto, I.
    Fellmann, M.
    Liguori, G.
    Lawendy, N.
    Cadatal, M. J.
    Lichtenstein, G. R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I538 - I539
  • [7] Association Between Smoking Status and the Efficacy and Safety of Tofacitinib in Patients with Ulcerative Colitis
    Rubin, David T.
    Torres, Joana
    Regueiro, Miguel
    Reinisch, Walter
    Prideaux, Lani
    Kotze, Paulo G.
    Tan, Fiona H.
    Gardiner, Sean
    Mundayat, Rajiv
    Cadatal, Mary Jane
    Ng, Siew C.
    [J]. CROHNS & COLITIS 360, 2024, 6 (01)
  • [8] Tofacitinib Effectiveness and Safety as Therapy for Ulcerative Colitis
    McNally, M.
    Keating, E.
    Gray, E.
    McCormick, E.
    Carroll, A.
    Palmer, C.
    Kennedy, U.
    McKiernan, S.
    MacCarthy, F.
    Dunne, C.
    Hartery, K.
    Egan, L.
    Slattery, E.
    Ryan, B.
    McNamara, D.
    O'Connor, A.
    Breslin, N.
    O'Donnell, S.
    Cullen, G.
    Mulcahy, H.
    Sheridan, J.
    Doherty, G.
    Kevans, D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I431 - I431
  • [9] EFFICACY AND SAFETY OF TOFACITINIB IN ULCERATIVE COLITIS PATIENTS WITH EXTRAINTESTINAL MANIFESTATIONS IN OCTAVE OPEN
    Rubin, David T.
    Vavricka, Stephan R.
    Armuzzi, Alessandro
    Dubinsky, Marla C.
    Sharara, Ala I.
    Modesto, Irene
    Fellmann, Marc
    Liguori, Giuseppina
    Lawendy, Nervin
    Cadatal, Mary Jane
    Lichtenstein, Gary R.
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S979 - S979
  • [10] Efficacy and safety of tofacitinib in Ulcerative Colitis patients with extraintestinal manifestations in OCTAVE Open
    Rubin, D. T.
    Vavricka, S. R.
    Armuzzi, A.
    Dubinsky, M. C.
    Sharara, A. I.
    Modesto, I.
    Fellmann, M.
    Liguori, G.
    Lawendy, N.
    Cadatal, M. J.
    Lichtenstein, G. R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I538 - I539
12345